Bsx nyse.

1.46b. PB Ratio. 4.353. Bid. 56.11. Bid Size. 2500. VWAP. 55.96737. Ask. 56.12. Ask Size. 200. Exchange. NYSE. Dividend. -. Ex-Div Date. -. Yield. N/A. Div.Boston Scientific Corporation. 01 Feb, 2023, 06:30 ET. MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the ...According to the latest 13F filings, Millennium Management owned 11 million shares of Boston Scientific Corporation (NYSE:BSX) at the end of September 2023 worth $561 million, representing 0.28% ...Nov 28, 2023 · Boston Scientific Corporation (NYSE:BSX) makes and sells medical devices. According to the latest 13F filings, Millennium Management owned 11 million shares of Boston Scientific Corporation (NYSE ...

Nov 17, 2023 · The public float for BSX is 1.46B, and at present, short sellers hold a 0.63% of that float. On November 17, 2023, the average trading volume of BSX was 8.51M shares. BSX) stock’s latest price update. Boston Scientific Corp. (NYSE: BSX) has seen a rise in its stock price by 1.52 in relation to its previous close of 53.85.

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.079 = US$2.3b ÷ (US$34b - US$4.6b) (Based on the trailing twelve months to September ...

Boston Scientific has a total shareholder equity of $19.1B and total debt of $8.9B, which brings its debt-to-equity ratio to 46.5%. Its total assets and total liabilities are $34.0B and $14.9B respectively. Boston Scientific's EBIT is $2.3B making its interest coverage ratio 9.2. It has cash and short-term investments of $952.0M.The latest price target for . Boston Scientific (NYSE: BSX) was reported by Canaccord Genuity on Monday, November 27, 2023.The analyst firm set a price target for 64.00 expecting BSX to rise to ...Real-time Price Updates for Boston Scientific Corp (BSX-N), along with buy or sell indicators, analysis, charts, historical performance, news and moreWebReturn on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.079 = US$2.3b ÷ (US$34b - US$4.6b) (Based on the trailing twelve months to September ...WebThe stock of Boston Scientific Corp. (NYSE: BSX) has decreased by -2.10 when compared to last closing price of 56.14.Despite this, the company has seen a loss of -1.31% in its stock price over the last five trading days. InvestorPlace reported 2023-11-28 that With their robustness and growth potential, healthcare stocks are becoming a focal ...

Member Rating. Recs. 0. TMFAdriaCimino ( < 20 ) Submitted: 2/20/2020 3:59:14 AM : Start Price: $42.31 NYSE:BSX Score: -3.47. Boston Scientific's many devices as well as a new duodenoscope, used in ERCP procedures will drive revenue. The duodenscope is significant because it is the first FDA-cleared single use one. Report this Post Reply.

During the last session, Boston Scientific Corp. (NYSE:BSX)’s traded shares were 7.46 million, with the beta value of the company hitting 0.77. At the end of the trading day, the stock’s price was $51.56, reflecting an intraday gain of 0.25% or $0.13. The 52-week high for the BSX share is $55.38 ...

Find the latest Boston Scientific Corporation (BSX) stock quote, history, news and other vital information to help you with your stock trading and investing.Potentially undervalued companies in the Healthcare industry. View Future Growth. Research Boston Scientific's (NYSE:BSX) stock key valuation metrics while comparing it …Fintel reports that on April 27, 2023, Barclays maintained coverage of Boston Scientific (NYSE:BSX) with a Overweight recommendation.. Analyst Price Forecast Suggests 7.78% Upside. As of April 24 ...WebView live Boston Scientific Corporation chart to track its stock's price action. Find market predictions, BSX financials and market news.Oct 11, 2023 · BSX 30-Year Financial Data. The intrinsic value of BSX. Boston Scientific is a leading producer of less invasive medical devices that are inserted into the human body through small openings or ...

(NYSE: BSX) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of -0.01%. What is BSX's Price Target? According to 17 Wall Street analyst s that have issued a 1 year BSX price target, the average BSX price target is $61.53 , with the highest BSX stock price forecast at $66.00 and the lowest BSX stock price forecast …Boston Scientific Corp. analyst ratings, historical stock prices, earnings estimates & actuals. BSX updated stock price target summary.Boston Scientific (NYSE: BSX) ... BSX stock is trading at 27x forward P/E based on our earnings forecast of $1.92 for 2023, compared to the last three-year average of 24x, implying that BSX stock ...MARLBOROUGH, Mass., Dec. 1, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, to sell its BTG Specialty Pharmaceuticals business for $800 …WebOn Oct 26, 2023, Boston Scientific ( NYSE: BSX) reported Q3 2023 earnings per share (EPS) of $0.34, up 183.33% year over year. Total Boston Scientific earnings for the quarter were $505.00 million. In the same quarter last year, Boston Scientific 's earnings per share (EPS) was $0.12. If you're new to stock investing, here's how to buy Boston ...Web

MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to ...

73.38%. Get the latest Boston Scientific Corporation (BSX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment... MARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single ...BSX - Boston Scientific Corp. Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company …19 Sept 2023 ... MARLBOROUGH, Mass., Sept. 19, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a ...Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. I.Find real-time BSX - Boston Scientific Corp stock quotes, company profile, news and forecasts from CNN Business.

Official news from Boston Scientific, a leading innovator of less invasive medical solutions that transform lives around the world. (NYSE: $BSX)

Oct 26, 2022 · MARLBOROUGH, Mass., Oct. 26, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.170 billion during the third quarter of 2022, growing 8.1 percent on a ...

9 Nov 2023 ... Boston Scientific (NYSE: BSX) reported its Q3 results last month, with revenues and earnings beating the street estimates.Boston Scientific has a total shareholder equity of $19.1B and total debt of $8.9B, which brings its debt-to-equity ratio to 46.5%. Its total assets and total liabilities are $34.0B and $14.9B respectively. Boston Scientific's EBIT is $2.3B making its interest coverage ratio 9.2. It has cash and short-term investments of $952.0M.Working together: Harbour Group team members John Gibbons, left, James Gibbons, Randall Krebs and Susan Trott, after ringing the bell at the Bermuda Stock Exchange (Photograph by Jessie Moniz Hardy)Web1. Confirmed cup and handle pattern on BSX chart Hi, please see the following chart pattern, that has been confirmed in the last weeks. Accordingly to the rules of the pattern, the price target is about 70$. If doesn't will come a market crash, there is a good opportunity, to reach the TP. The price action is supported with the AI hype, that is ...Russell Investments Group Ltd. reduced its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 23.6% in the 2nd quarter, according to the company in its most recent Form 13F ...MARLBOROUGH, Mass., Oct. 26, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.170 billion during the third quarter of 2022, growing 8.1 percent on a ...In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that determination. To view a list of securities that are subject to delisting, including those that continue to be traded pending appeal, please click here.WebMARLBOROUGH, Mass., Aug. 19, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc.(LSE: BTG) pursuant to the previously ...Earnings for Boston Scientific are expected to grow by 10.95% in the coming year, from $2.01 to $2.23 per share. Boston Scientific has not formally confirmed its next …Bleakley Financial Group LLC boosted its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 1.7% in the second quarter, according to its most recent Form 13F filing with the SEC.The ...Web

Boston Scientific has a total shareholder equity of $19.1B and total debt of $8.9B, which brings its debt-to-equity ratio to 46.5%. Its total assets and total liabilities are $34.0B and $14.9B respectively. Boston Scientific's EBIT is $2.3B making its interest coverage ratio 9.2. It has cash and short-term investments of $952.0M.Boston Scientific (NYSE: BSX) ... BSX stock is trading at 27x forward P/E based on our earnings forecast of $1.92 for 2023, compared to the last three-year average of 24x, implying that BSX stock ...26 Apr, 2023, 06:30 ET. MARLBOROUGH, Mass., April 26, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing ...Instagram:https://instagram. wells fargo financialsetf that tracks oil priceambetter from sunshine health reviewsbest landlord insurance california 27 Jun 2023 ... PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Jessica L. Mega and Susan E. Morano to its ...Each major bond market around the world has its own closing hours, but the New York Stock Exchange (NYSE) closes at 4:30 p.m. EST, according to the Financial Web. Bond trading begins on the NYSE at 9:30 a.m. EST. vanguard 500 index admldo dispensaries take insurance Dec 1, 2023 · Financial Performance. In 2022, BSX's revenue was $12.68 billion, an increase of 6.68% compared to the previous year's $11.89 billion. Earnings were $642.00 million, a decrease of -34.82%. Financial Statements. checkpoint stock Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) StudyOn October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ...